Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

Teva cuts 25% of workforce, with Israel taking a heavy toll

But share prices increase by almost 14%

Amazon’s invasion

Jeff Bezos’ new move isn’t the problem you think it is - it’s worse

Bristol-Myers Squibb (BMS) building

BMS adds another Ono drug to its immuno-oncology portfolio

Pharma giant hopes its new candidate can follow in the footsteps of Opdivo

Sanofi reception

Sanofi/Regeneron start first filings for PD-1 drug cemiplimab

The pharma partners begin with a skin cancer filing to the US FDA

Sanofi reception

Sanofi/Regeneron start first filings for PD-1 drug cemiplimab

The pharma partners begin with a skin cancer filing to the US FDA

- PMLiVE

Agios appoints Celgene’s Jackie Fouse

She joins the pharma group’s board of directors

Conversis appoints new vendor manager

Gina Gulotta joins the translation provider from RWS

Brexit talks threaten supply of medical technologies

As concern grows that the outcome could undermine the regulatory framework

- PMLiVE

Vivid MedComms bolster their business with a new senior appointment

A new hire for Vivid MedComms, part of the Lucid Group of companies

Lucid Group Communications Limited

Evolve and thrive vs wait and wither

What is the future of your marketing function?

Sanofi reception

After some big setbacks, Sanofi talks up its R&D portfolio

Hopes its pipeline of 71 projects delivers strong sales

- PMLiVE

Gilead adds to CAR-T assets with Cell Design Labs buyout

Gains full control of the biotherapeutics firm following its acquisition of Kite Pharma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links